10.1111/bph.15661 25 AndersonL
What you need to know: Blood tests to check kidney function are routine when taking these medications Temporary changes in kidney function tests can occur with Mounjaro, but often stabilise or improve with continued treatment People with significant kidney problems may need lower doses or more careful monitoring When to contact your doctor Contact your healthcare provider immediately if you experience: Severe nausea, vomiting, or diarrhoea that prevents you from keeping fluids down Unusual muscle weakness, tingling, or numbness (possible signs of high potassium) Dizziness or fainting, especially when standing up Significant decreases in urination Irregular heartbeat or palpitations These symptoms could indicate a potential complication that needs prompt attention
GLP-1, short for glucagon-like peptide-1 , is a hormone naturally produced in your small intestine after you eat
While Novo Nordisk and Eli Lilly continue to dominate today's commercial landscape, these results are another reminder that the next wave of obesity innovation is coming from a broader group of companiesmany with strong links to China's rapidly expanding biotech ecosystem
The FDA cited three deaths among the patients, includ" TikTok10.3M views Are GLP-1 drugs really just overpriced flops in disguise
Putting the trial numbers into perspective Historically, anti-obesity drugs produced average weight losses in the single digits (510%), and even the best options rarely approached double-digit percentages at the population level